Kestra Medical Technologies Scheduled to Present at 44th Annual J.P. Morgan Healthcare Conference

Kestra Medical Technologies will present at the J.P. Morgan Healthcare Conference on January 13, 2026, at 2:15 p.m. PT.

Quiver AI Summary

Kestra Medical Technologies, Ltd., a company specializing in wearable medical devices and digital healthcare, will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 at 2:15 p.m. Pacific Time. The presentation will be available for live streaming and replay on the company's investor relations website. Kestra focuses on improving patient outcomes in cardiovascular disease through advanced monitoring and therapeutic technologies designed to be intuitive and connected. More information about the company can be found on their website.

Potential Positives

Kestra Medical Technologies' participation in the prestigious 44th Annual J.P. Morgan Healthcare Conference highlights the company's industry recognition and offers a platform to showcase its innovations to key stakeholders.
The live webcast format of the presentation allows for broader accessibility, potentially attracting interest from a wider audience of investors and healthcare professionals.

Potential Negatives

None

FAQ

What is Kestra Medical Technologies, Ltd.?

Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company focused on improving outcomes in cardiovascular disease.

When will Kestra Medical present at the J.P. Morgan Healthcare Conference?

Kestra Medical is scheduled to present on Tuesday, January 13 at 2:15 p.m. Pacific Time.

How can I watch the Kestra Medical presentation?

Interested parties can access the live webcast and replay on the Kestra Medical investor relations website.

What technologies does Kestra Medical focus on?

Kestra Medical specializes in monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected for cardiovascular care.

Where can I find more information about Kestra Medical Technologies?

More information can be found by visiting Kestra Medical's official website at www.kestramedical.com.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$KMTS Revenue

$KMTS had revenues of $19.4M in Q1 2026.

You can track KMTS financials on Quiver Quantitative's KMTS stock page.

$KMTS Hedge Fund Activity

We have seen 55 institutional investors add shares of $KMTS stock to their portfolio, and 25 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 1,582,693 shares (+42.8%) to their portfolio in Q3 2025, for an estimated $37,604,785
CITADEL ADVISORS LLC removed 1,508,298 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,837,160
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,299,391 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,873,530
PRICE T ROWE ASSOCIATES INC /MD/ added 842,382 shares (+84.5%) to their portfolio in Q3 2025, for an estimated $20,014,996
BROWN ADVISORY INC added 679,335 shares (+117.1%) to their portfolio in Q3 2025, for an estimated $16,140,999
HOOD RIVER CAPITAL MANAGEMENT LLC added 395,238 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,390,854
INVESCO LTD. removed 212,166 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,041,064

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$KMTS Analyst Ratings

Wall Street analysts have issued reports on $KMTS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 12/12/2025
BTIG issued a "Buy" rating on 11/18/2025
Wells Fargo issued a "Overweight" rating on 07/17/2025

To track analyst ratings and price targets for $KMTS, check out Quiver Quantitative's $KMTS forecast page.

$KMTS Price Targets

Multiple analysts have issued price targets for $KMTS recently. We have seen 4 analysts offer price targets for $KMTS in the last 6 months, with a median target of $29.0.

Here are some recent targets:

David Roman from Goldman Sachs set a target price of $25.0 on 12/15/2025
Larry Biegelsen from Wells Fargo set a target price of $28.0 on 12/12/2025
Matt O'Brien from Piper Sandler set a target price of $30.0 on 12/12/2025
Marie Thibault from BTIG set a target price of $32.0 on 11/18/2025

Full Release

KIRKLAND, Wash., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 2:15 p.m. Pacific Time.

Interested parties may access the live webcast and replay of the presentation by visiting the Kestra Medical Technologies investor relations website .

About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com .